Results 161 to 170 of about 88,736 (267)

Association Between Colorectal Cancer Screening and Survival in Patients Older Than 70 Years: Results of A National Multicenter Retrospective Study

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Colorectal cancer screening mainly targets a population between 50 and 70 years of age; however, it is inconsistently implemented in people over 70. The aim of this study was to analyze the association between colorectal cancer (CRC) screening, postoperative mortality, and perioperative and oncologic outcomes in a large population ...
Matteo Rottoli   +499 more
wiley   +1 more source

Robotic‐Assisted Versus Laparoscopic‐Assisted Colectomy: Findings on Short‐Term Outcomes From A Multi‐Institutional Propensity Score‐Matched Study

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The present study compared the short‐term outcomes and perioperative complications of robotic‐assisted colectomy (RAC) and laparoscopic‐assisted colectomy (LAC) in patients with colon cancer. This retrospective study included patients with histologically confirmed colon adenocarcinoma who underwent either RAC or LAC at five medical centers in ...
Ching‐Wen Huang   +5 more
wiley   +1 more source

ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy. [PDF]

open access: yesArq Bras Cir Dig
Ribas-Filho JM   +9 more
europepmc   +1 more source

Exome Sequencing Identifies Variants in MLH1 and ERBB2 as Potential Cancer‐Predisposing Factors in Familial Early‐Onset Colorectal Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Colorectal cancer (CRC) has raised considerable health concerns worldwide, with increasing incidence rates, specifically among younger populations. Despite remarkable progress in diagnosing and treating various diseases, the genetic basis of CRC remains only partially understood.
Behnaz Bagheri   +7 more
wiley   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma

open access: yesMolecular Carcinogenesis, EarlyView.
ABSTRACT Functional DNA methylation abnormalities are a hallmark of human cancers and may be a promising biomarker for their early diagnosis. Moreover, the largest methylation differences can improve the sensitivity of noninvasive diagnoses of solid tumors.
Junsheng Zhao   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy